Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Shares Outstanding: 2023-2025

Historic Shares Outstanding for Artiva Biotherapeutics (ARTV) over the last 3 years, with Sep 2025 value amounting to $24.5 million.

  • Artiva Biotherapeutics' Shares Outstanding rose 1.06% to $24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 million, marking a year-over-year increase of 1.06%. This contributed to the annual value of $24.3 million for FY2024, which is 2899.86% up from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Shares Outstanding of $24.5 million as of Q3 2025, which was up 0.62% from $24.4 million recorded in Q2 2025.
  • Artiva Biotherapeutics' Shares Outstanding's 5-year high stood at $24.5 million during Q3 2025, with a 5-year trough of $805,199 in Q2 2023.
  • Over the past 3 years, Artiva Biotherapeutics' median Shares Outstanding value was $14.0 million (recorded in 2024), while the average stood at $12.9 million.
  • Data for Artiva Biotherapeutics' Shares Outstanding shows a peak YoY soared of 2,908.69% (in 2025) over the last 5 years.
  • Artiva Biotherapeutics' Shares Outstanding (Quarterly) stood at $809,758 in 2023, then skyrocketed by 2,899.86% to $24.3 million in 2024, then grew by 1.06% to $24.5 million in 2025.
  • Its last three reported values are $24.5 million in Q3 2025, $24.4 million for Q2 2025, and $24.4 million during Q1 2025.